JP Morgan Chase & Co (JPM) 64.25 $JPM The Week Ahead in

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
JP Morgan Chase & Co (JPM) 64.25 $JPM

The Week Ahead in Financials: Visa, HSBC and Berkshire Hathaway on Deck for Earnings
Alex DUMORTIER, CFA, The Motley Fool - Motley Fool - Sun Nov 01, 12:43PM CST
Next week, three stalwarts of the financial sector, HSBC Holdings plc (NYSE: HSBC),  Visa Inc (NYSE: V) and Berkshire Hathaway Inc (NYSE: BRK-B)will report quarterly earnings -- here's what investors need to know: Visa is reportedly on the...
PSX: 89.05 (+2.62), V: 77.58 (-0.93), JPM: 64.25 (-0.96), HSBC: 39.07 (-0.16), MA: 98.99 (-1.60)

Jim Cramer -- Why You Must Own Apple, Starbucks and Biogen in November
at The Street - Sat Oct 31, 9:15AM CDT
There's still a lot of weakness across many sectors, Cramer says. That's why these are the 3 stocks to own.
SBUX: 62.57 (+0.07), BIIB: 290.51 (-3.21), JPM: 64.25 (-0.96), BAC: 16.78 (-0.31), WFC: 54.14 (-0.95), AAPL: 119.50 (-1.03)

Facebook, Visa To Carry IBD 50 Earnings To Peak
at Investor's Business Daily - Sat Oct 31, 7:02AM CDT
Earnings season for the IBD 50 is nearing its peak, with leaders like Facebook (FB) and Visa (V) due to report in the coming week. More than two-thirds of S&P 500 companies have released quarterly results so far, and a Thomson Reuters report said 72%...
V: 77.58 (-0.93), JPM: 64.25 (-0.96), FB: 101.97 (-2.91), GOOGL: 737.39 (-7.46), GTN: 15.89 (+0.19), AAPL: 119.50 (-1.03), MA: 98.99 (-1.60), REGN: 557.39 (-2.63), PAYC: 38.01 (-0.88)

Fed Proposes 'Too Big To Fail' Bank Buffer Rules
at Investor's Business Daily - Fri Oct 30, 4:37PM CDT
The Federal Reserve Board proposed long-awaited rules for reining in losses from institutions deemed "too big to fail." It requires the eight largest banks to raise a total of $120 billion in debt that could be converted into equity in a crisis. New...
GS: 187.50 (-2.39), JPM: 64.25 (-0.96), C: 53.17 (-0.49), WFC: 54.14 (-0.95), BAC: 16.78 (-0.31), MS: 32.97 (-0.57)


Fed looks at way to shift big-bank losses to investors
By MARCY GORDON - AP - Fri Oct 30, 4:03PM CDT
WASHINGTON (AP) — In their latest bid to reduce the chances of future taxpayer bailouts, federal regulators are proposing that the eight biggest U.S. banks build new cushions against losses that would shift the burden to investors.
JPM: 64.25 (-0.96), C: 53.17 (-0.49), WFC: 54.14 (-0.95), BAC: 16.78 (-0.31), MS: 32.97 (-0.57)

Fitch Rates J.P. Morgan Mortgage Trust 2015-6
Business Wire - Fri Oct 30, 3:47PM CDT
Fitch Ratings rates J.P. Morgan Mortgage Trust 2015-6 (JPMMT 2015-6) as follows:
JPM: 64.25 (-0.96)

Morgan Stanley Investment Management Announces Portfolio Management Changes for Morgan Stanley Emerging Markets Debt Fund, Inc. and Morgan Stanley Emerging Markets Domestic Debt Fund, Inc.
Business Wire - Fri Oct 30, 3:30PM CDT
Morgan Stanley Investment Management announced today portfolio management changes for Morgan Stanley Emerging Markets Debt Fund, Inc. (NYSE: MSD) and Morgan Stanley Emerging Markets Domestic Debt Fund, Inc. (NYSE: EDD) (the "Funds". The Funds are managed by the Emerging Markets Debt team of Morgan Stanley Investment Management Inc. (the "Adviser". The team consists of portfolio managers, analysts and traders. The members of the team jointly and primarily responsible for the day-to-day management of each Fund are Eric J. Baurmeister, a Managing Director of the Adviser, Jens Nystedt, a Managing Director of the Adviser, Warren Mar, a Managing Director of the Adviser, and Sahil Tandon, an Executive Director of the Adviser. Mr. Baurmeister has been associated with the Adviser in an investment management capacity since 1997. Mr. Baurmeister began managing Morgan Stanley Emerging Markets Debt Fund, Inc. in July 2002 and Morgan Stanley Emerging Markets Domestic Debt Fund, Inc. at its inception in April 2007. Mr. Nystedt has been associated with the Adviser in an investment management capacity since November 2014. Prior to November 2014, Mr. Nystedt was a Senior Global Strategist at Moore Capital Management from November 2008 to November 2014. Mr. Mar has been associated with the Adviser in an investment management capacity since August 2012. Prior to August 2012, Mr. Mar was the global head of Emerging Markets Corporate Research & Strategy at J.P. Morgan Chase from April 2004 to August 2012. Mr. Tandon has been associated with the Adviser in an investment management capacity since 2004.
JPM: 64.25 (-0.96), EDD: 7.54 (+0.05), MSD: 8.74 (unch), MS: 32.97 (-0.57)

Stocks Fall Back Into Red as Financials Lag
at The Street - Fri Oct 30, 1:55PM CDT
Stocks fall back into the red Friday afternoon as a lag in financial stocks overshadows a push higher by the energy sector.
BUD: 119.33 (+1.59), VRX: 93.77 (-17.73), C: 53.17 (-0.49), FNFG: 10.35 (-0.03), XOM: 82.74 (+0.51), BAC: 16.78 (-0.31), WFC: 54.14 (-0.95), KEY: 12.42 (-0.96), SBUX: 62.57 (+0.07), FSLR: 57.07 (+6.08), RDS.A: 52.46 (-0.10), JPM: 64.25 (-0.96), LNKD: 240.87 (+23.87), SCTY: 29.65 (-8.42), CVS: 98.78 (-5.02), BP: 35.70 (-0.01), ABBV: 59.55 (+5.45), XLF: 24.08 (-0.35), CVX: 90.88 (+0.99), PTR: 78.63 (+1.17), XLE: 68.03 (+0.44), STO: 16.16 (+0.19), CL: 66.35 (-2.88)

Bank Stock Roundup: Rate Hike Stance Bring Citigroup, JPMorgan in Focus at the Tail End of Q3 Earnings
Zacks Equity Research - Zacks Investment Research - Fri Oct 30, 1:43PM CDT
Over the last five trading days, all eyes were on the Federal Reserve's two-day FOMC meeting. Additionally, earnings season for the banking stocks was coming to an end.
RF: 9.35 (-0.29), COF: 78.90 (-1.30), JPM: 64.25 (-0.96), C: 53.17 (-0.49), BAC: 16.78 (-0.31)

The Simple Reason Warren Buffett Loves This Stock
John Maxfield, The Motley Fool - Motley Fool - Fri Oct 30, 1:40PM CDT
It's no coincidence that Warren Buffett looks for investments with durable competitive advantages, and that his own company, Berkshire Hathaway , owns 10% of Wells Fargo , the nation's  fourth biggest bank by assets . I say that because Wells...
JPM: 64.25 (-0.96), BAC: 16.78 (-0.31), WFC: 54.14 (-0.95), TIF: 82.44 (+1.13)

12 Companies Who Have Cut Jobs in 2015
Madeleine Johnson - Zacks Investment Research - Fri Oct 30, 11:47AM CDT
Here's a look at 12 companies who have cut jobs in 2015.
WFM: 29.96 (-0.19), BIIB: 290.51 (-3.21), JPM: 64.25 (-0.96), HAL: 38.38 (+0.19), WMT: 57.24 (-0.72), DB: 27.95 (+0.06), CAT: 72.99 (+1.02), PG: 76.38 (-0.64), MSFT: 52.64 (-0.72), TWTR: 28.46 (-0.60), HPQ: 26.96 (-0.41), SLB: 78.16 (-0.53), BHI: 52.68 (+0.09)

IHS Chairman and CEO Jerre Stead and CFO Todd Hyatt to Present at J.P. Morgan Ultimate Services Investor Conference on Nov. 10, 2015; and at Wells Fargo Technology & Media Conference on Nov. 11, 2015
Business Wire - Fri Oct 30, 7:00AM CDT
IHS Inc. (NYSE: IHS), the leading global source of critical information and insight, today announced that Jerre Stead, IHS chairman and CEO, and Todd Hyatt, IHS executive vice president and chief financial officer, will present an overview of the company at two upcoming conferences:
IHS: 119.54 (-1.43), JPM: 64.25 (-0.96), WFC: 54.14 (-0.95)

Deutsche Bank Retreat Follows JPMorgan, BofA, Citi
at Investor's Business Daily - Thu Oct 29, 3:51PM CDT
Deutsche Bank (DB) said it will shed 35,000 jobs, close operations in 10 countries and suspend its dividend for two years as it posted a $6.6 billion third-quarter loss. Most of the job reductions -- 20,000 of them -- will come via selling off some...
JPM: 64.25 (-0.96), C: 53.17 (-0.49), DB: 27.95 (+0.06), BAC: 16.78 (-0.31)

Pacific Retail Capital Partners and Silverpeak Real Estate Partners Join J.P. Morgan as Ownership Group for Paseo Nuevo Shopping Center
Business Wire - Thu Oct 29, 1:59PM CDT
A partnership between Pacific Retail Capital Partners and Silverpeak Real Estate Partners announced today that it has formed a joint venture with institutional investors advised by J.P. Morgan Asset Management as owners of the 154,900-square-foot Paseo Nuevo specialty Shops and Restaurants in Santa Barbara. Located on the Pacific Coast between Los Angeles and San Francisco, Paseo Nuevo has become an integral component of the downtown experience.
JPM: 64.25 (-0.96)

Stocks Are Slightly Lower; Oil Tops $46
at The Street - Thu Oct 29, 1:55PM CDT
Stocks are slightly lower by mid-afternoon Thursday with the energy sector struggling to stay positive as crude oil tops $46 a barrel.
PSX: 89.05 (+2.62), GPRO: 25.00 (-0.62), PBR.A: 3.99 (+0.06), WBK: 22.37 (-0.16), C: 53.17 (-0.49), PFE: 33.82 (-0.95), AMGN: 158.18 (-2.40), DB: 27.95 (+0.06), PYPL: 36.01 (+0.10), WFC: 54.14 (-0.95), BAC: 16.78 (-0.31), MGM: 23.19 (+0.39), AGN: 308.47 (+4.09), JPM: 64.25 (-0.96), BP: 35.70 (-0.01), TWC: 189.40 (-2.42), SNY: 50.34 (+0.71), YELP: 22.25 (-0.70), XLF: 24.08 (-0.35), MA: 98.99 (-1.60), XLE: 68.03 (+0.44)

Chase Receives J.D. Power's Top Rank for Small Business Banking in West and Midwest Regions for 2015
M2 - Thu Oct 29, 12:42PM CDT
Chase ranked highest in customer satisfaction in the West and Midwest Regions, and second highest in customer satisfaction in the Northeast and South Regions, according to the 2015 J.D. Power study released today. This is the third year in a row that Chase has ranked highest in customer satisfaction in the West Region.
JPM: 64.25 (-0.96)

The Most Interesting Bank in America
John Maxfield, The Motley Fool - Motley Fool - Thu Oct 29, 12:31PM CDT
The Bank of New York Mellon is an atypical bank. It doesn't have an expansive branch network. It doesn't advertise widely. And it tends to steer away from doing business with normal folk like you and me. It specializes instead in acting as a...
STT: 69.00 (-0.78), JPM: 64.25 (-0.96), USB: 42.18 (-0.82), BAC: 16.78 (-0.31), BK: 41.65 (-0.80)

Virtusa Gives JPMorgan, Other Clients Tech Edge
at Investor's Business Daily - Thu Oct 29, 12:21PM CDT
You may not have heard of Virtusa, a tech outsourcing and consulting firm that helps businesses develop their IT systems. But you've probably heard of some of its clients, which have included high-profile names such as JPMorgan Chase (JPM), American...
SYNT: 47.04 (-0.25), WIT: 12.38 (+0.01), JPM: 64.25 (-0.96), IBM: 140.08 (-0.47), VRTU: 57.43 (+0.39), INFY: 18.16 (-0.13), AIG: 63.06 (-0.43), TRI: 41.02 (-0.39)

J.P. Morgan Asset Management Releases 2016 Long-term Capital Markets Assumptions, Presents Views on Strategic Portfolio Allocations and Realistic Return Expectations
PR Newswire - Thu Oct 29, 11:00AM CDT
J.P. Morgan Asset Management today released its 2016 Long-term Capital Markets Assumptions (LTCMA) whitepaper, a carefully formulated, comprehensive perspective on long-term asset class returns and risks designed to guide investors when determining, reviewing and analyzing their strategic portfolio allocations. The LTCMA, celebrating its 20th anniversary, are constructed by some of the firm's most senior investors and present long-term return, risk and correlation estimates that encompass more than 50 asset and strategy classes, and are published for investors in 10 different base currencies.
JPM: 64.25 (-0.96)

Stocks Slip as Deutsche Bank Leads Financials Lower
at The Street - Thu Oct 29, 10:35AM CDT
Stocks retreat on Thursday after third-quarter U.S. GDP slows and as Deutsche Bank leads the financial sector lower.
GPRO: 25.00 (-0.62), WBK: 22.37 (-0.16), C: 53.17 (-0.49), PFE: 33.82 (-0.95), DB: 27.95 (+0.06), AMGN: 158.18 (-2.40), COP: 53.35 (-0.27), BAC: 16.78 (-0.31), WFC: 54.14 (-0.95), PYPL: 36.01 (+0.10), BWLD: 154.27 (+1.82), MGM: 23.19 (+0.39), AGN: 308.47 (+4.09), JPM: 64.25 (-0.96), TWC: 189.40 (-2.42), XLF: 24.08 (-0.35), YELP: 22.25 (-0.70), SNY: 50.34 (+0.71), MA: 98.99 (-1.60)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ensign Lawsuit Brews: Investor Stakes High by Dec. 7

Updated Category News Views 40

Ensign's Alleged Missteps Uncovered Man, grabbing headlines in the finance world often feels like catching a whirlwind, and yet, here we are with Ensign Group's latest debacle. This isn't some run-of-the-mill story we're sifting through. It's a class action lawsuit with teeth, aiming to rope in investors who played ball during a hefty stretch running from February 10,...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 273

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 240

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Updated Category News Views 167

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 0

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 121

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 120

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 184

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Duolingo Faces Class Action: Deadline Looms for Plaintiffs

Updated Category News Views 208

Shaking up the education sector like a hot potato, investors have been thrown for a loop with Duolingo’s latest legal debacle. News broke that Kahn Swick & Foti, LLC, with significant backing from their heavyweight partner and former Louisiana Attorney General Charles C. Foti Jr., is spearheading a class action lawsuit against Duolingo, Inc. (NasdaqGS: DUOL). It’s one...

Continue Reading
York Space Systems Class Action: Deadline Approaches

Updated Category News Views 135

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Continue Reading

Top 5 Most Recently Viewed Articles

MAAS Embraces Healthcare with Strategic Carve Group Acquisition

Updated Category News Views 117

MAAS Expands into Healthcare and Wellness Maase Inc. (NASDAQ: MAAS) recently announced a significant expansion into the healthcare and wellness sector following its acquisition of Carve Group Ltd. This strategic move signifies MAAS's commitment to innovate within the traditional wellness product landscape by integrating advanced biotechnology. The acquisition is more than...

Continue Reading
Metavesco Welcomes ADHC's Strategic Purchase of OTCfi Tokens

Updated Category News Views 117

Metavesco Celebrates Collaboration with ADHC In a significant development, Metavesco, Inc. (NASDAQ: MVCO) recently expressed excitement over American Diversified Holdings Corporation (NASDAQ: ADHC) announcing their Digital Asset Treasury (DAT) purchase of OTCfi tokens. This partnership is seen as a positive move towards enhancing the visibility and growth of the...

Continue Reading
Understanding Short Interest Trends in Discover Financial

Updated Category News Views 188

Understanding Short Interest Trends in Discover Financial Discover Financial's stock ticker, DFS, has recently experienced an increase in its short interest, rising to 10.94% since the last report. The total number of shares sold short now stands at 3.11 million, equating to 1.42% of the available shares for trading. If we consider the current trading volume, it would...

Continue Reading
Immunic Reaches Key Milestone in Multiple Sclerosis Trials

Updated Category News Views 201

Immunic Completes Enrollment in Phase 3 Trials Immunic, Inc. (NASDAQ: IMUX), a pioneering biotechnology firm, recently reached a significant milestone by completing enrollment for its Phase 3 ENSURE trials, which focus on its lead drug, vidofludimus calcium. These trials target patients living with relapsing multiple sclerosis (RMS) and aim to evaluate the drug's...

Continue Reading
Ergonomic Apparel Revolution: Elevating Back Health in Daily Life

Updated Category News Views 86

Rising Trend of Ergonomic Posture Wear The growing trend of ergonomic apparel highlights the importance of posture-related health concerns. As people spend more time seated and engaged with screens, discomfort is becoming increasingly common. A recent review has brought attention to this phenomenon, shedding light on how ergonomic clothing can play a pivotal role in...

Continue Reading